Moderna chief executive Stephane Bancel said on Saturday his company will charge governments between Rs 1,855 ($ 25) and Rs 2,755 ($ 37) per dose of its COVID-19 vaccine candidate.
Speaking to German weekly Welt am Sonntag (WamS), Barcel said the price of the coronavirus vaccine will depend on the number of doses ordered by governments.
“So our vaccine costs roughly the same as a flu shot, which is between $ 10 and $ 50,” he said.
On Monday, an EU official involved in the negotiations said the European Commission wanted to strike a deal with Moderna to provide millions of doses of its candidate vaccine at a price of less than $ 25 per dose.
“Nothing is signed yet, but we are close to concluding a deal with the European Commission. We want to deliver Europe and are in constructive talks,” Bancel told WamS, adding that it was only a “matter of days” until a contract is ready.
Moderna said its investigational vaccine was 94.5% effective in preventing COVID-19, based on interim data from an advanced clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.
The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July.
(With contributions from Reuters)